Get complete Patent Opposition Report for Lek Pharmaceuticals Dd

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Lek Pharmaceuticals Dd's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2981520Mar 6, 2019New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine2
EP2697251Feb 27, 2019A Method For Controlling The Main Complex N-Glycan Structures And The Acidic Variants And Variability In Bioprocesses Producing Recombinant Proteins2
EP2501799Jan 24, 2018Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) Content1